The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Adamyan L.V.

National medical research center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov;
Russian university of medicine

Yarmolinskaya M.I.

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott;
North-Western State Medical University named after I.I. Mechnikov

«5 P» strategy of modern contraception

Authors:

Adamyan L.V., Yarmolinskaya M.I.

More about the authors

Journal: Russian Journal of Human Reproduction. 2024;30(1): 122‑134

DOI: 10.17116/repro202430011122

Read: 2850 times

Download PDF (RU)
Contact the author
Table of contents

«5 P» STRATEGY OF MODERN CONTRACEPTION
«5 P» STRATEGY OF MODERN CONTRACEPTION

To cite this article:

Adamyan LV, Yarmolinskaya MI. «5 P» strategy of modern contraception. Russian Journal of Human Reproduction. 2024;30(1):122‑134. (In Russ.)
https://doi.org/10.17116/repro202430011122

 
Подписка 2026 Проблемы репродукции (Russian Journal of Human Reproduction)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Analysis of medi­cal preventive stru­ctures staff resources in 2023. Russian Journal of Preventive Medi­cine. 2024;(10):45-51
Proton pump inhi­bitors: posi­tive and nega­tive properties. On the 45th anni­versary of their discovery. Russian Journal of Preventive Medi­cine. 2024;(11):135-140
Study of opinions of medi­cal students on medi­cal prevention issues. Russian Journal of Preventive Medi­cine. 2024;(12):69-74
Asse­ssment of risk of deve­loping fractures and sarcopenia and quality of life of patients with chro­nic kidney disease at the outpatient stage. Russian Journal of Preventive Medi­cine. 2024;(12):88-91
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
Orga­nizational issues of reproductive health protection of adolescent girls in the system of the Fede­ral Medi­cal and Biological Agency of Russia. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):7-13
Asse­ssment of risk factors for breast cancer deve­lopment in women living in the Sara­tov region. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):100-106
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Prevention of periodontal inflammation in microgravity mode­ling. Stomatology. 2024;(6-2):23-28
Effe­ctiveness of risk-guided cardiac mana­gement in patients with HER2-positive breast cancer and cancer therapy-related cardiac dysfunction. Russian Cardiology Bulletin. 2024;(4-2):144-153
Abstract:

The demographic situation in the world is characterized by a progressive decline in birth rates and a population decline. In this regard, a systemic approach aimed at improving women’s reproductive health. The modern trend is the 5P medicine: predictive, preventive, personalized, participatory and positive. This direction fully reflects the strategy of preventing abortions. The article discusses predictors of unplanned pregnancy, early and late complications of abortion, personalized approach strategy, and the need for motivated choice of contraceptive methods, the importance of comprehensive counseling to increase adherence to the chosen method, and additional preventive benefits of hormonal contraception. The article emphasizes that contraception is not about reducing birth rates but an effective prevention of abortions and a contribution to preserving women’s reproductive health.

Keywords:

reproductive health
contraception
abortions
5P medicine
prevention

Authors:

Adamyan L.V.

National medical research center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov;
Russian university of medicine

Yarmolinskaya M.I.

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott;
North-Western State Medical University named after I.I. Mechnikov

Received:

07.12.2023

Accepted:

10.12.2023

Close metadata

References:

  1. Ohrana reproduktivnogo zdorov’ya rabotnikov. Osnovnye terminy i ponyatiya. Glossariy. Punkt 7.2. (Utv. Departamentom gossanepidnadzora Minzdrava RF 2 oktyabrya 2003 g. N II-8/13-09). Accessed September 19, 2023. (In Russ.). https://base.garant.ru/4180230/
  2. Enthoven CA, El Marroun H, Koopman-Verhoeff ME, Jansen W, Lambregtse-van den Berg MP, Sondeijker F, Hillegers MHJ, Bijma HH, Jansen PW. Clustering of characteristics associated with unplanned pregnancies: The Generation R Study. BMC Public Health. 2022;22(1):1957. https://doi.org/10.1186/s12889-022-14342-y
  3. The Lancet. Abortion: access and safety worldwide. The Lancet. 2018;391(10126):1121. https://doi.org/10.1016/s0140-6736(18)30624-x
  4. Osipova I. Reproductive attitudes of Russians and attitude to state measures to support fertility. Demograficheskoe obozrenie. 2020; 7(2):97-120. (In Russ.). https://doi.org/10.17323/demreview.v7i2.11143
  5. Kazenin KI. Birth rate in Russia in 2020: regional dynamics. Ekonomicheskoe razvitie Rossii. 2021;28(3):50-54. (In Russ.).
  6. Nacional’nye medicinskie kriterii priemlemosti metodov kontracepcii. Adaptirovannyj dokument «Medicinskie kriterii priemlemosti ispol’zovaniya metodov kontracepcii VOZ, 5 izdanie, 2015». Pod red. Suhih G.T., Prilepskoj V.N. M. 2023. (In Russ.).
  7. Bi S, Zhang L, Chen J, Huang M, Huang L, Zeng S, Li Y, Liang Y, Jia J, Wen S, Cao Y, Wang S, Xu X, Feng L, Zhao X, Zhao Y, Zhu Q, Qi H, Zhang L, Li H, Wang Z, Du L, Chen D. Maternal age at first cesarean delivery related to adverse pregnancy outcomes in a second cesarean delivery: a multicenter, historical, cross-sectional cohort study. BMC Pregnancy and Childbirth. 2021;21(1):126.  https://doi.org/10.1186/s12884-021-03608-9
  8. Lin WH, Liu CH, Yi CC. Exposure to sexually explicit media in early adolescence is related to risky sexual behavior in emerging adulthood. PLoS One. 2020;15(4):e0230242. https://doi.org/10.1371/journal.pone.0230242
  9. Kratkie itogi vyborochnogo obsledovaniya «sem’ya i rozhdaemost». Accessed September 19, 2023. (In Russ.). https://rosstat.gov.ru/storage/mediabank/%D0%9A%D1%80%D0%B0%D1%82%D0%BA%D0%B8%D0%B5%20%D0%B8%D1%82%D0%BE%D0%B3%D0%B8%20%D0%B2%D1%8B%D0%B1%D0%BE%D1%80%D0%BE%D1%87%D0%BD%D0%BE%D0%B3%D0%BE%20%D0%BE%D0%B1%D1%81%D0%BB%D0%B5%D0%B4%D0%BE%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F%20_%D0%A1%D0%B5%D0%BC%D1%8C%D1%8F%20%D0%B8%20%D1%80%D0%BE%D0%B6%D0%B4%D0%B0%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C.html
  10. Armashevskaya OV, Sokolovskaya TA, Senenko Ash. The current priorities of contraceptive behavior in Russian able-bodied women (according to a sampling study). Akusherstvo i ginekologiya. 2021; 1:164-169. (In Russ.). https://doi.org/10.18565/aig.2021.1.164-169
  11. Bearak J, Popinchalk A, Ganatra B, Moller AB, Tunçalp Ö, Beavin C, Kwok L, Alkema L. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019. The Lancet Global Health. 2020; 8(9):e1152-e1161. https://doi.org/10.1016/S2214-109X(20)30315-6
  12. Dobrohotova YuE, Bykova OA. Reproductive Behavior — Justification for a Combined Approach. StatusPraesens. Ginekologiya, akusherstvo, besplodnyj brak. 2020;1(suppl):1-5. (In Russ.).
  13. Barton K, Redshaw M, Quigley MA, Carson C. Unplanned pregnancy and subsequent psychological distress in partnered women: a cross-sectional study of the role of relationship quality and wider social support. BMC Pregnancy and Childbirth. 2017;17(1):44.  https://doi.org/10.1186/s12884-017-1223-x
  14. World Health Organization. Abortion. World Health Organization. Published November 25, 2021. Accessed September 19, 2023. https://www.who.int/news-room/fact-sheets/detail/abortion
  15. Abortion Statistics — Worldometer. https://www.worldometers.info/abortions
  16. PRB. Abortion: A Global Overview. PRB. Published May 24, 2022. Accessed September 19, 2023. https://www.prb.org/resources/abortion-a-global-overview/
  17. Oficial’nyj sajt Ministerstva zdravoohraneniya Rossijskoj Federacii. Accessed September 19, 2023. (In Russ.). https://minzdrav.gov.ru
  18. Hohmann-Marriott BE. Unplanned pregnancies in New Zealand. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2017;58(2):247-250.  https://doi.org/10.1111/ajo.12732
  19. Petrov AYu, Uzbekova LD, Sereda EV. Immediate and long-term consequences of an artificial termination of pregnancy. Mezhdunarodnyj nauchno-issledovatel’skij zhurnal. 2022;6-2(120):131-134. (In Russ.). https://doi.org/10.23670/IRJ.2022.120.6.055
  20. Orazov MR, Radzinsky VE, Volkova SV, Hamoshina MB, Mihaleva LM, Abitova MZ, Shustova VB. Chronic endometritis in women with endometriosis-associated infertility. Ginekologiya. 2020; 22(3):15-20. (In Russ.). https://doi.org/10.26442/20795696.2020.3.200174
  21. Hohmann-Marriott BE. Unplanned pregnancies of women with chronic health conditions in New Zealand. New Zealand Medical Journal. 2019;132(1499):11-17. 
  22. Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011;84(3):230-233.  https://doi.org/10.1016/j.contraception.2011.01.013
  23. Aborty v Rossii: statistika do 2019 goda, prichiny. Accessed September 19, 2023. (In Russ.). https://rosinfostat.ru/statistika-abortov-v-rossii-po-dannym-rosstat
  24. Sonfield A, Hasstedt K, Gold RB. Moving Forward: Family Planning in the Era of Health Reform. New York: Guttmacher Institute; 2014. Accessed September 19, 2023.
  25. Hooper DJ. Attitudes, Awareness, Compliance and Preferences among Hormonal Contraception Users. Clinical Drug Investigation. 2010;30(11):749-763.  https://doi.org/10.2165/11538900-000000000-00000
  26. Osnovnye pokazateli zdorov’ya materi i rebenka, deyatel’nost’ sluzhby ohrany detstva i rodovspomozheniya v Rossijskoj Federacii, 2022 god. Accessed September 19, 2023. (In Russ.). https://minzdrav.gov.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-materialy/statisticheskiy-sbornik-2018-god
  27. United Nations. Contraceptive Use by Method 2019. Data Booklet; 2019. Accessed September 19, 2023. https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf
  28. Burke W, Barkley J, Barrows E, Brooks R, Gecsi K, Huber-Keener K, Jeudy M, Mei S, O’Hara JS, Chelmow D. Executive Summary of the Ovarian Cancer Evidence Review Conference. Obstetrics and Gynecology. 2023;142(1):179-195.  https://doi.org/10.1097/aog.0000000000005211
  29. Cho MK. Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam Medical Journal. 2018;54(3):153.  https://doi.org/10.4068/cmj.2018.54.3.153
  30. Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. The Lancet Oncology. 2015; 16(9):1061-1070. https://doi.org/10.1016/S1470-2045(15)00212-0
  31. Schrijver LH, Antoniou AC, Olsson H, Mooij TM, Roos-Blom MJ, Azarang L, Adlard J, Ahmed M, Barrowdale D, Davidson R, Donaldson A, Eeles R, Evans DG, Frost D, Henderson A, Izatt L, Ong KR, Bonadona V, Coupier I, Faivre L, Fricker JP, Gesta P, van Engelen K, Jager A, Menko FH, Mourits MJE, Singer CF, Tan YY, Foretova L, Navratilova M, Schmutzler RK, Ellberg C, Gerdes AM, Caldes T, Simard J, Olah E, Jakubowska A, Rantala J, Osorio A, Hopper JL, Phillips KA, Milne RL, Beth Terry M, Noguès C, Engel C, Kast K, Goldgar DE, van Leeuwen FE, Easton DF, Andrieu N, Rookus MA; Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study. American Journal of Obstetrics and Gynecology. 2021; 225(1):51.e1-51.e17.  https://doi.org/10.1016/j.ajog.2021.01.014
  32. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT. Combined Oral Contraceptive Use and Epithelial Ovarian Cancer Risk. Epidemiology. 2008;19(2):237-243.  https://doi.org/10.1097/ede.0b013e31816334c5
  33. Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. The Lancet. 2008;371(9609):303-314.  https://doi.org/10.1016/s0140-6736(08)60167-1
  34. Iodice S, Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P, Bernard L, Maisonneuve P, Gandini S. Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis. European Journal of Cancer. 2010;46(12):2275-2284. https://doi.org/10.1016/j.ejca.2010.04.018
  35. Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner’s oral contraception study. BMJ. 2007;335(7621):651.  https://doi.org/10.1136/bmj.39289.649410.55
  36. Michels KA, Brinton LA, Pfeiffer RM, Trabert B. Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study. American Journal of Epidemiology. 2018;187(8):1630-1641. https://doi.org/10.1093/aje/kwx388
  37. Rogers LM, Cordero AM, Pfeiffer CM, Hausman DB, Tsang BL, De-Regil LM, Rosenthal J, Razzaghi H, Wong EC, Weakland AP, Bailey LB. Global folate status in women of reproductive age: a systematic review with emphasis on methodological issues. Annals of the New York Academy of Sciences. 2018;1431(1):35-57.  https://doi.org/10.1111/nyas.13963
  38. Bender A, Hagan KE, Kingston N. The association of folate and depression: A meta-analysis. Journal of Psychiatric Research. 2017; 95:9-18.  https://doi.org/10.1016/j.jpsychires.2017.07.019
  39. Peng Y, Dong B, Wang Z. Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: A cohort study based on 1999-2010 National Health and Nutrition Examination Survey (NHANES). International Journal of Cardiology. 2016;219:136-142.  https://doi.org/10.1016/j.ijcard.2016.06.024
  40. Vidmar M, Grželj J, Mlinarič-Raščan I, Geršak K, Dolenc MS. Medicines associated with folate—homocysteine—methionine pathway disruption. Archives of Toxicology. 2018;93(2):227-251.  https://doi.org/10.1007/s00204-018-2364-z
  41. Sun CF, Liu H, Hao YH, Hu HT, Zhou ZY, Zou KX, Liu XM, Sheng JZ, Ding GL, Huang HF. Association between gestational anemia in different trimesters and neonatal outcomes: a retrospective longitudinal cohort study. World Journal of Pediatrics. 2021; 17(2):197-204.  https://doi.org/10.1007/s12519-021-00411-6
  42. Klinicheskie rekomendacii. Anomal’nye matochnye krovotecheniya. Rossijskoe obshchestvo akusherov-ginekologov, 2021. (In Russ.).
  43. Dikke GB, Erofeeva LV. Contraception in Russia today: Use and awareness (A population-based study). Akusherstvo i ginekologiya. 2016;2:108-113. (In Russ.). https://doi.org/10.18565/aig.2016.2.108-113
  44. Klinicheskie rekomendacii. Mioma matki. Rossijskoe obshchestvo akusherov-ginekologov, 2020. (In Russ.).
  45. Klinicheskie rekomendacii. Sindrom polikistoznyh yaichnikov. Rossijskoe obshchestvo akusherov-ginekologov, Rossijskaya associaciya endokrinologov, 2021. (In Russ.).
  46. Yarmolinskaya MI, Adamyan LV. Hormonal contraceptives and endometriosis: modern view on the problem. Problemy reprodukcii. 2020;26(3):39-45. (In Russ.). https://doi.org/10.17116/repro20202603139
  47. Andreeva EN, Absatarova YS. Premenstrual syndrome: a review of the literature. Gynecologiya. 2019;21(2):38-43. (In Russ.). https://doi.org/10.26442/20795696.2019.2.190341
  48. Kontracepciya posle aborta. Accessed September 19, 2023. (In Russ.). https://www.ru486.ru/doctor_contr.htm
  49. Sakevich IV, Denisov BP. The Latest Trends in Reproductive Health and the Problem of Abortion in Russia: the latest trends. Sotsiologicheskie issledovaniya. 2019;(11):140-151. (In Russ.). https://doi.org/10.31857/s013216250007457-5
  50. Merki-Feld GS, Caetano C, Porz TC, Bitzer J. Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO Study. The European Journal of Contraception and Reproductive Health Care. 2018;23(3):183-193.  https://doi.org/10.1080/13625187.2018.1465546
  51. Grossman D, Fernández L, Hopkins K, Amastae J, Potter JE. Perceptions of the safety of oral contraceptives among a predominantly Latina population in Texas. Contraception. 2010;81(3):254-260.  https://doi.org/10.1016/j.contraception.2009.09.009
  52. Hladky KJ, Allsworth JE, Madden T, Secura GM, Peipert JF. Womenʼs Knowledge about Intrauterine Contraception. Obstetrics and Gynecology. 2011;117(1):48-54.  https://doi.org/10.1097/aog.0b013e318202b4c9
  53. Bitzer J, Marin V, Lira J. Contraceptive counselling and care: a personalized interactive approach. The European Journal of Contraception and Reproductive Health Care. 2017;22(6):418-423.  https://doi.org/10.1080/13625187.2017.1414793
  54. Dehlendorf C, Fitzpatrick J, Steinauer J, Swiader L, Grumbach K, Hall C, Kuppermann M. Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling. Patient Education and Counseling. 2017;100(7): 1374-1381. https://doi.org/10.1016/j.pec.2017.02.009
  55. Pazol K, Zapata LB, Dehlendorf C, Malcolm NM, Rosmarin RB, Frederiksen BN. Impact of Contraceptive Education on Knowledge and Decision Making: An Updated Systematic Review. American Journal of Preventive Medicine. 2018;55(5):703-715.  https://doi.org/10.1016/j.amepre.2018.07.012
  56. Rivlin K, Isley MM. Patient-centered Contraceptive Counseling and Prescribing. Clinical Obstetrics and Gynecology. 2018;61(1):27-39.  https://doi.org/10.1097/grf.0000000000000337
  57. Tomaszewski J, Paszkowski T, Romuald Dębski, et al. [The CHOICE study (Contraceptive Health Research of Informed Choice Experience) — an educational research program for Polish women planning combined hormonal contraceptives use]. Ginekologia Polska. 2012;83(6):417-423. 
  58. Nelson HD, Cantor A, Jungbauer RM, Eden KB, Darney B, Ahrens K, Burgess A, Atchison C, Goueth R, Fu R. Effectiveness and Harms of Contraceptive Counseling and Provision Interventions for Women. Annals of Internal Medicine. 2022;175(7):980-993.  https://doi.org/10.7326/m21-4380
  59. Van Look PFA, Cottingham J. The World Health Organization’s Safe Abortion Guidance Document. American Journal of Public Health. 2013;103(4):593-596.  https://doi.org/10.2105/ajph.2012.301204
  60. Apolihkina IA, Gorbunova EA, Kubitskaya YV, Ipatova MV, Kuzemin AA. Rehabilitation of women after surgical abortion in the first trimester: whose responsibility? Medicinskij sovet. 2015;(11):84-89. (In Russ.). https://doi.org/10.21518/2079-701X-2015-11-84-89
  61. Unanyan AL, Arakelov SE, Polonskaya LS, Guriev TD, Alimov VA, Baburin DV, Kadyrova AE, Kossovich YuM. Postabortal rehabilitation: theoretical and practical aspects. Medicinskij sovet. 2014;(9): 26-29. (In Russ.). https://doi.org/10.21518/2079-701x-2014-9-26-29
  62. Che Y, Liu X, Zhang B, Cheng L. Oral contraception following abortion. Medicine. 2016;95(27):e3825. https://doi.org/10.1097/md.0000000000003825
  63. Medikamentoznyj abort v ambulatornoj praktike. Pod redakciej Dikke G.B. M.: GEOTAR-Media; 2018. (In Russ.).
  64. Landersoe SK, Birch Petersen K, Sørensen AL, Larsen EC, Martinussen T, Lunding SA, Kroman MS, Nielsen HS, Nyboe Andersen A. Ovarian reserve markers after discontinuing long-term use of combined oral contraceptives. Reproductive BioMedicine Online. 2020;40(1):176-186.  https://doi.org/10.1016/j.rbmo.2019.10.004
  65. Girum T, Wasie A. Return of fertility after discontinuation of contraception: A systematic review and meta-analysis. Contraception and Reproductive Medicine. 2018;3:9.  https://doi.org/10.1186/s40834-018-0064-y
  • Braems G, Denys H, De Wever O, Cocquyt V, Van den Broecke R. Use of tamoxifen before and during pregnancy. The Oncologist. 2011;16(11):1547-51.  https://doi.org/10.1634/theoncologist.2011-0121
  • Egashira K, Hiasa K, Yokota N, Kawamura T, Matsushita T, Okugawa K, Yahata H, Sonoda K, Kato K. Infertility after abdominal trachelectomy. Acta Obstetricia et Gynecologica Scandinavica. 2018; 97(11):1358-1364. https://doi.org/10.1111/aogs.13429
  • Schimberni M, Morgia F, Colabianchi J, Giallonardo A, Piscitelli C, Giannini P, Montigiani M, Sbracia M. Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. Fertility and Sterility. 2009;92(4):1297-1301. https://doi.org/10.1016/j.fertnstert.2008.07.1765
  • De Marco MP, Montanari G, Ruscito I, Giallonardo A, Ubaldi FM, Rienzi L, Costanzi F, Caserta D, Schimberni M, Schimberni M. Natural Cycle Results in Lower Implantation Failure than Ovarian Stimulation in Advanced-Age Poor Responders Undergoing IVF: Fertility Outcomes from 585 Patients. Reproductive Sciences. 2021; 28(7):1967-1973. https://doi.org/10.1007/s43032-020-00455-5
  • Chan JL, Johnson LN, Efymow BL, Sammel MD, Gracia CR. Outcomes of ovarian stimulation after treatment with chemotherapy. Journal of Assisted Reproduction and Genetics. 2015;32(10):1537-1545. https://doi.org/10.1007/s10815-015-0575-2
  • Checa Vizcaíno MA, Corchado AR, Cuadri ME, Comadran MG, Brassesco M, Carreras R. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. Reproductive Biomedicine Online. 2012;24(6):606-610.  https://doi.org/10.1016/j.rbmo.2012.02.020
  • Oktay K, Türkçüoğlu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reproductive Biomedicine Online. 2010;20(6):783-788.  https://doi.org/10.1016/j.rbmo.2010.03.004
  • Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. Journal of Clinical Oncology. 2008;26(16):2630-2635. https://doi.org/10.1200/JCO.2007.14.8700
  • Turan V, Bedoschi G, Moy F, Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertility and Sterility. 2013;100(6):1681-5.e1.  https://doi.org/10.1016/j.fertnstert.2013.08.030
  • Rosenberg E, Fredriksson A, Einbeigi Z, Bergh C, Strandell A. No increased risk of relapse of breast cancer for women who give birth after assisted conception. Human Reproduction Open. 2019;(4): hoz039. https://doi.org/10.1093/hropen/hoz039
  • Sonigo C, Sermondade N, Calvo J, Benard J, Sifer C, Grynberg M. Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2019;4:100049. https://doi.org/10.1016/j.eurox.2019.100049
  • Bonardi B, Massarotti C, Bruzzone M, Goldrat O, Mangili G, Anserini P, Spinaci S, Arecco L, Del Mastro L, Ceppi M, Demeestere I, Lambertini M. Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 2020;10:574669. https://doi.org/10.3389/fonc.2020.574669
  • Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Human Reproduction. 2000;15(1):165-170.  https://doi.org/10.1093/humrep/15.1.165
  • Holzer H, Scharf E, Chian RC, Demirtas E, Buckett W, Tan SL. In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation. Fertility and Sterility. 2007;88(1):62-67.  https://doi.org/10.1016/j.fertnstert.2006.11.087
  • Kedem A, Yerushalmi GM, Brengauz M, Raanani H, Orvieto R, Hourvitz A, Meirow D. Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation. Journal of Assisted Reproduction and Genetics. 2018;35(5): 851-856.  https://doi.org/10.1007/s10815-018-1153-1
  • Park CW, Lee SH, Yang KM, Lee IH, Lim KT, Lee KH, Kim TJ. Cryopreservation of in vitro matured oocytes after ex vivo oocyte retrieval from gynecologic cancer patients undergoing radical surgery. Clinical and Experimental Reproductive Medicine. 2016;43(2):119-125.  https://doi.org/10.5653/cerm.2016.43.2.119
  • Kawamura K, Cheng Y, Kawamura N, Takae S, Okada A, Kawagoe Y, Mulders S, Terada Y, Hsueh AJ. Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes. Human Reproduction. 2011;26(11):3094-3101. https://doi.org/10.1093/humrep/der282
  • Mohsenzadeh M, Khalili MA, Tabibnejad N, Yari N, Agha-Rahimi A, Karimi-Zarchi M. Embryo Cryopreservation Following In-Vitro Maturation for Fertility Preservation in a Woman with Mullerian Adenosarcoma: A Case Report. Journal of Human Reproductive Sciences. 2017;10(2):138-141.  https://doi.org/10.4103/jhrs.JHRS_93_16
  • Kirillova A, Bunyaeva E, Van Ranst H, Khabas G, Farmakovskaya M, Kamaletdinov N, Nazarenko T, Abubakirov A, Sukhikh G, Smitz JEJ. Improved maturation competence of ovarian tissue oocytes using a biphasic in vitro maturation system for patients with gynecological malignancy: a study on sibling oocytes. Journal of Assisted Reproduction and Genetics. 2021;38(6):1331-1340. https://doi.org/10.1007/s10815-021-02118-z
  • Sanchez F, Le AH, Ho VNA, Romero S, Van Ranst H, De Vos M, Gilchrist RB, Ho TM, Vuong LN, Smitz J. Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles. Journal of Assisted Reproduction and Genetics. 2019;36(10):2135-2144. https://doi.org/10.1007/s10815-019-01551-5
  • De Roo C, Tilleman K. In Vitro Maturation of Oocytes Retrieved from Ovarian Tissue: Outcomes from Current Approaches and Future Perspectives. Journal of Clinical Medicine. 2021;10(20):4680. https://doi.org/10.3390/jcm10204680
  • Dinikina YuV, Belogurova MB, Govorov IE, Gamzatova ZKh, Pervunina TM, Komlichenko EV. Cryopreservation of ovarian tissue in girls with oncological diseases: a multidisciplinary approach. Rossijskij zhurnal detskoj gematologii i onkologii. 2019;6(3):59-67.  https://doi.org/10.21682/2311-1267-2019-6-3-59-67
  • Abakushina EV, Otoi T, Kaprin AD. Recovery options of reproductive function of cancer patients due to transplantation of cryopreserved ovarian tissue. Geny i kletki. 2015;10(1):18-27. (In Russ.).
  • Gougeon A, Chainy GB. Morphometric studies of small follicles in ovaries of women at different ages. Journal of Reproduction and Fertility. 1987;81(2):433-442.  https://doi.org/10.1530/jrf.0.0810433
  • Dolmans MM, von Wolff M, Poirot C, Diaz-Garcia C, Cacciottola L, Boissel N, Liebenthron J, Pellicer A, Donnez J, Andersen CY. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertility and Sterility. 2021;115(5):1102-1115. https://doi.org/10.1016/j.fertnstert.2021.03.008
  • Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. Journal of Assisted Reproduction and Genetics. 2015;32(8):1167-1170. https://doi.org/10.1007/s10815-015-0544-9
  • Roness H, Meirow D. Fertility preservation: Follicle reserve loss in ovarian tissue transplantation. Reproduction. 2019;158(5):F35-F44.  https://doi.org/10.1530/REP-19-0097
  • Nisolle M, Casanas-Roux F, Qu J, Motta P, Donnez J. Histologic and ultrastructural evaluation of fresh and frozen-thawed human ovarian xenografts in nude mice. Fertility and Sterility. 2000;74(1): 122-129.  https://doi.org/10.1016/s0015-0282(00)00548-3
  • Tanaka A, Nakamura H, Tabata Y, Fujimori Y, Kumasawa K, Kimura T. Effect of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogels on frozen-thawed human ovarian tissue in a xenograft model. The Journal of Obstetrics and Gynaecology Research. 2018;44(10):1947-1955. https://doi.org/10.1111/jog.13726
  • Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5(1):e8772. https://doi.org/10.1371/journal.pone.0008772
  • Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908-2914. https://doi.org/10.1182/blood-2010-01-265751
  • Diaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I, Cobo A, Remohí J, Pellicer A. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertility and Sterility. 2018;109(3):478-485.e2.  https://doi.org/10.1016/j.fertnstert.2017.11.018
  • Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, Bellon JR, Wong JS, Smith BL, Harris JR. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. Journal of Clinical Oncology. 2011;29(29): 3885-3891. https://doi.org/10.1200/JCO.2011.36.1105
  • Gellert SE, Pors SE, Kristensen SG, Bay-Bjørn AM, Ernst E, Yding Andersen C. Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort. Journal of Assisted Reproduction and Genetics. 2018;35(4):561-570.  https://doi.org/10.1007/s10815-018-1144-2
  • Salim N, Tumanova K, Stolbovoy A, Zvereva D, Popodko A Nosov V. Adaptive VMAT Radiotherapy to Avoid Brachytherapy in Cervical Cancer Treatment. International Journal of Radiation Oncology and Biology and Physics. 2022;114(supp 3):e262.
  • Bystrova O, Lapina E, Kalugina A, Lisyanskaya A, Tapilskaya N, Manikhas G. Heterotopic transplantation of cryopreserved ovarian tissue in cancer patients: a case series. Gynecological Endocrinology. 2019;35(12):1043-1049. https://doi.org/10.1080/09513590.2019.1648413
  • Donnez J. Chemotherapy and decline of the ovarian reserve: How can we explain it and how to prevent it? Fertility and Sterility. 2020; 114(4):722-724.  https://doi.org/10.1016/j.fertnstert.2020.08.010
  • ESHRE Guideline Group on Female Fertility Preservation; Anderson RA, Amant F, Braat D, D’Angelo A, Chuva de Sousa Lopes SM, Demeestere I, Dwek S, Frith L, Lambertini M, Maslin C, Moura-Ramos M, Nogueira D, Rodriguez-Wallberg K, Vermeulen N. ESHRE guideline: female fertility preservation. Human Reproduction Open. 2020;2020(4):hoaa052. https://doi.org/10.1093/hropen/hoaa052
  • Kindinger LM, Kyrgiou M, MacIntyre DA, Cacciatore S, Yulia A, Cook J, Terzidou V, Teoh TG, Bennett PR. Preterm Birth Prevention Post-Conization: A Model of Cervical Length Screening with Targeted Cerclage. PLoS One. 2016;11(11):e0163793. https://doi.org/10.1371/journal.pone.0163793
  • Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P, Paraskevaidis E. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633. https://doi.org/10.1136/bmj.i3633
  • Li X, Li J, Wu X. Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: A systematic review. European Journal of Cancer. 2015;51(13):1751-1759. https://doi.org/10.1016/j.ejca.2015.05.012
  • Kasuga Y, Ikenoue S, Tanaka M, Ochiai D. Management of pregnancy after radical trachelectomy. Gynecological Oncology. 2021; 162(1):220-225.  https://doi.org/10.1016/j.ygyno.2021.04.023
  • Šimják P, Cibula D, Pařízek A, Sláma J. Management of pregnancy after fertility-sparing surgery for cervical cancer. Acta Obstetricia et Gynecologica Scandinavia. 2020;99(7):830-838.  https://doi.org/10.1111/aogs.13917
  • Sato Y, Hidaka N, Sakai A, Kido S, Fujita Y, Okugawa K, Yahata H, Kato K. Evaluation of the efficacy of vaginal progesterone in preventing preterm birth after abdominal trachelectomy. European Journal of Obstetrics Gynecology and Reproducive Biology. 2021;259: 119-124.  https://doi.org/10.1016/j.ejogrb.2021.02.009
  • Signorello LB, Cohen SS, Bosetti C, Stovall M, Kasper CE, Weathers RE, Whitton JA, Green DM, Donaldson SS, Mertens AC, Robison LL, Boice JD Jr. Female survivors of childhood cancer: preterm birth and low birth weight among their children. Journal of National Cancer Institute. 2006;98(20):1453-1461. https://doi.org/10.1093/jnci/djj394
  • Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. Journal of Clinical Oncology. 2003;21(6):1180-1189. https://doi.org/10.1200/JCO.2003.10.019
  • Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D. Female fertility and colorectal cancer. International Journal of Colorectal Diseases. 2008;23(8):735-743.  https://doi.org/10.1007/s00384-008-0483-3
  • Lopategui DM, Yechieli R, Ramasamy R. Oncofertility in sarcoma patients. Translational Andrology and Urology. 2017;6(5):951-958.  https://doi.org/10.21037/tau.2017.07.03
  • Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertility and Sterility. 2013;99(1):37-43.  https://doi.org/10.1016/j.fertnstert.2012.09.028
  • Akhmedova ZB, Umarova SG, Ashurova MJ. Fertility and Hodgkin’s lymphoma. Vestnik Avicennyt. 2013;(2):167-172. (In Russ.).
  • Hodgson DC, Pintilie M, Gitterman L, Dewitt B, Buckley CA, Ahmed S, Smith K, Schwartz A, Tsang RW, Crump M, Wells W, Sun A, Gospodarowicz MK. Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematological Oncology. 2007;25(1):11-15.  https://doi.org/10.1002/hon.802
  • Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH, Burnett AK. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer. 1999;86(7):1231-1239. https://doi.org/10.1002/(sici)1097-0142(19991001)86:7<1231::aid-cncr18>3.0.co;2-y
    • Contact the author
    Email
    Message
    The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

    Email Confirmation

    An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

    Email Confirmation

    Contact us
    If you have any questions, complaints or suggestions, please use this feedback form.
    Email
    Message
    The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
    Submit Application

    You can become an author of one of our magazines, send a request and we will consider it in during the day.

    Name
    Phone
    E-mail
    Message
    Login
    Registration
    E-mail
    Password
    Forgot Password?

    Log in to the site using your account in one of the services

    Password recovery
    E-mail
    Login
    Register

    We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.